At least 46 interactome studies, broad at proteome scale or biologically more focused, have together mapped about 75,000 human protein-protein interactions (PPIs). Many of the studies addressed local interactome data paucity analyzing specific homeostatic and regulatory systems, with recent focus demonstrating the involvement of post-translational protein modification (PTM) enzyme families in a wide range of cellular functions. These datasets provided insight into binding mechanisms, the dynamic modularity of complexes or delineated combinatorial enzymatic cascades. Furthermore, the combined study of PPI and PTM dynamics has begun to reveal conditional rewiring of molecular networks through PTMmediated recognition events. Taken together these studies highlight the utility of local and global interaction networks to functionally prioritize the many changing PTMs mapped in human cells. 
Introduction
Most cellular functions are in large part driven by the coordinated action of multiple macro-molecular assemblies of interacting protein subunits. Defining the molecular architecture of how these individual protein building blocks interact is a major task fundamental to a better understanding of cellular processes in health and disease [1, 2] . Both broad and focused protein-protein interaction (PPI) studies have recently dented interactome data paucity and provided novel insight into a diverse array of cellular systems. Yet, the mapping of conditional interactions, that is, interactions that are strengthened or loosened under specific conditions and thus change with changing conditions, has just started [3] . Here, we collect recent systematically generated human interaction data: focused studies that lead to functional or mechanistic insights as well as broad, proteome wide PPI data resources. We further point out that interaction approaches are particularly useful in understanding of post-translational modification (PTM)-mediated signaling, both in defining modifying enzyme relationships and in delineating PTM-dependent, conditional interactions. Finally, we highlight how collated interactome data can be used in conjugation with PTM data to extract biological signals from PTM collections and drive insight into PTM signaling.
Recent progress in systematic human PPI mapping
Generating datasets broad in scope is fundamental to interactome mapping, providing an increasingly better framework for further analysis. Much of the work to improve data quality focused on determining and improving the specificity of large scale PPI approaches [4] [5] [6] . Given high specificity, it is relatively low coverage large unbiased data sets suffer from. Comprehensive interactome mapping requires both search space and interaction coverage: that is, methods that scale well with the number of protein pairs/complexes to be assayed and high sensitivity of the methods to actually detect the interactions in the search space. As such methods have substantially improved. For example Y2H approaches have seen second generation sequencing techniques utilized to reduce work load and increase sensitivity in large data set generation [7 ,8 ] . Two mass spectrometry (MS) based approaches extensively fractionated human culture cells to infer interaction relationships from the obtained cofractionation patterns [9 ,10 ] . Affinity purification of cell cycle related proteins [11] and protein complexes immunoprecipitated using $1800 antibodies targeted against more than 1000 transcription co-regulatory proteins [12] lead to additional substantial human interactome data sets (Table 1) . Also, luminescence based co-IP methods, originally coined LUMIER, have been further exploited as a stringent pair wise PPI screening system [13 ,14,15 ] . Ultimately, high coverage data will result from combining interactomes generated with different approaches. For example in yeast two-hybrid (Y2H) analyses, weaker, more transient interactions can be better sampled [16] because interactions are measured out of a binding equilibrium via transcriptional reporter activity, and not the physical interacting proteins as such. Therefore Y2H data contain, for example, a larger fraction of signaling interactions while more cooperative associations in processes like transcription and protein homeostasis are generally better covered in complex based approaches. Table 1 Large human protein-protein interaction data sets. Table summarizes data sets generated in a systematic, well controlled way. Studies are described by listing first author + year, ENTREZ pub med identifier, the topic of the study, number of baits, number of preys(in binary approaches) or the search space, the number of PPIs, main PPI screening method and the reference. Single protein data sets have not been included even though they report many, sometimes hundreds, of interactions. Further, significant data sets have been published describing interactions from organisms such as E. coli, yeast, C. elegans, Drosophila or Arabidopsis which are not considered here. PPI data sets must carefully be quality controlled either empirically [4, 17] , through benchmarking [18] or, for the folded part of the proteome, assessed through structural modeling [19, 20] . Computational scoring of PPIs, for example, using network properties [21, 22] , can be very useful for high quality network construction, however the method of choice strongly depends on the biological questions asked. PPI detection methods, PPI quality measures, scoring and PPI databases have been subject of comprehensive recent reviews including Refs. [17, 18, 20] . Please refer to Table 1 for a summary of recent large-scale human interactome mapping studies.
Human protein interaction networks Woodsmith and Stelzl 35

Study
These interaction datasets, along with other recent well controlled high throughput (HTP) studies, are invaluable for their unbiased approach. They collectively fuel advanced integrative approaches, 'big data' modeling and clinical data interpretation [23, 24] . On the cellular systems level, they are fundamental to the interpretation of genetic and protein variation and can lead to mechanistic insight ( Figure 1a ). For example, Lee et al. recently derived the likely mis-location of >150 proteins in glioma from a combination of PPIs, expression data and biochemical protein features [25] . This analysis derived how ectopic network structure, driven by alterations in gene expression profiles, can lead to alteration of protein localization, and by proxy altered protein function in disease.
In isolation however, precisely this global interactome approach can predicate detailed mechanistic understanding of specific systems, as global mapping more or less randomly samples a subset of the interactions from large search spaces at relatively low coverage. It is difficult to answer specific mechanistic questions with sparse and somewhat technically biased data, rather the value is the high quality data resource as such and biological insight is given in form of novel global analyses, statistical trends, testable hypotheses and unexpected leads. Biologically focused screens sample a smaller number of potential interactions much more thoroughly, providing high coverage data to enable a better dynamic and mechanistic view of specific cellular processes or protein assemblies. High coverage interaction mapping among the components of relatively well defined molecular systems, for example, the spliceosome [26 ] , can shed new light on the potential subunit interplay and here led to unforeseen mechanistic details with regards to the dynamics of sub-complex rearrangement in the course of spliceosome assembly and intron excision. Conversely, the potential functional repertoire of less well characterized groups of proteins, such as tetraspanins [27] or tandem-BRCT domain proteins [28] , are more consistently defined through focused interactome mapping approaches.
Characterizing the PTM modifying enzyme interaction space
Many of the recent PPI sets focused on modifying enzymes, that is, kinases, phosphatases, methyltransferases, deacetylases, and E2/E3 ubiquitin ligases (Table 1) . PTM systems, as defined through writer/reader/eraser/substrate components [29] , are requisite for cellular functioning. Ectopic expression or activity can cause a wide variety of human diseases, reflected in the number of pharmaceuticals targeted at PTM components currently in clinical trials [30] . Despite this, the vast majority of research has been restricted to just a small fraction of PTM components such as the 'hottest' 50 kinases [31] , highlighting the need for more systematic approaches. Also, more than 100,000 PTMs contrast the relatively small number of enzymes that mediate modification and leave the substrate-enzyme relationships largely elusive. In addition, interactions involving PTM-enzymes are thought to be relatively weak and transient thus suffer from poor coverage in the current global interactome data. Several recent interactome studies focusing on PTM-enzymes have been conducted using distinct methodological approaches and provided context for orphan or poorly annotated nodes in PTM networks, highlighting hitherto unknown functions controlled by PTM systems ( Figure 1B(i) ).
Many studies have tackled interactomes of disease relevant single kinases such as BCR-ABL [32, 33] or LRRK2 [34] . Providing a more global context for kinase function, two recent studies by Varjosalo et al. presented proteomic analysis of complexes of a large number of human CMGC kinases [35 ] and of selected kinases from other major families [6] . 481 and 345 co-complex members were identified for 57 and 32 kinases (512 and 488 PPIs) via LC-MS/MS, in the two studies respectively. Not surprisingly, interaction partners of the different kinases point towards their involvement in many different cellular processes. Only the most closely related kinases show significant overlapping interaction pattern and no kinase family trends are apparent, suggesting largely non-redundant functions for the enzymes. Together with global phospho-site information these data provide a basis for the inference of kinase-substrate networks as suggested for SRPK1 and SRPK2 and their spliceosomal substrates [35 ] .
AP-MS approaches were further utilized to assess the modular composition of the human phosphatase PP2A complex through affinity purification of the individual subunits [36, 37] . Covering the complexes in extensive reciprocal purifications, the two studies observe pronounced modularity of the holo-PP2A complexes including, for example, a Striatin, STRIP1/2, CTTNBP2NL, MST4 containing module.
Two large Y2H studies [38, 39] 
RNAi knockdowns of 45 MAPK-interacting proteins.
Vinayagam et al. [39] used overexpression perturbation analysis of 50 proteins in the network to assess the directionality of signal flow through the large network. Though all these kinase/phosphatase interactome studies elaborate on very different aspects in their data analyses, they commonly broaden our view of phosphorylation function in the cell ( Figure 1B(i) ).
Similarly, less intensively studied PTM systems have also received recent attention. Affinity purifications from cultured T-cells [40] provided binding profiles for all 11 cytoplasmic and nuclear 'histone' deacetylase proteins (HDACs). Protein methylation related enzymes were investigated in an analogous approach using a novel Y2H methodology to define sets of putative methylation targets and regulators for 22 protein methyltransferases and demethylases [7 ] . Both of these studies highlighted the underappreciated functions for these PTMs outside of their canonical role in epigenetic regulation of transcription, with many interactors [7 ] or the enzymes themselves [40] residing outside of the nucleus. These and other studies (Table 1) provide direct systematic evidence for alternate, cytoplasmic PTM functions through observed interaction profiles, significantly extending anecdotal evidence collected from a handful of small scale studies.
Many kinases are known to require the chaperone HSP90, a quality control system of protein folding, for activity. Through study of HSP90 interactions with 314 kinases, using a modified LUMIER system, Taipale et al. [15 ] could begin to unravel global principles of protein client recognition ( Figure 1B(ii) ). Interestingly they could rule out simple explanations of single amino acid determinants of binding, instead providing evidence that HSP90 could distinguish clients from none clients based on intrinsic protein stability. This applied kinome wide and could discriminate between highly homologous kinases such as ARAF and BRAF.
PTM systems such as phosphorylation operate using a direct enzyme-substrate mechanism, however the ubiquitin and ubiquitin-like families of enzymes represent a key challenge in network biology as they operate in a combinatorial, hierarchical enzymatic cascade [41, 42] . The pairwise permutations of $40 E2 conjugating enzymes with >300 E3 ligases, in combination with specific partner preferences within E3 ligase multimers, together control the target and architecture of ubiquitin modification, and are thus crucial to understanding regulation in ubiquitin biology ( Figure 1B(iii) ). Three distinct Y2H studies tackled the $12,000 putative E3 RING ligase interactions with their cognate E2 conjugation enzymes [43] [44] [45] , highlighting the utility in using multiple Y2H experimental set-ups to address interaction space coverage. These papers revealed similar patterns of E2 binding with several E2s (UBE2Ds/Es/W and N) appearing to operate as ubiquitination work horses, engaging in many interactions with a wide variety of E3 RINGs. Conversely, some E3s are highly selective, interacting with one or few E2 enzymes (e.g. ARIH1-UBE2L3/6, MARCH10-UBE2N/K). These and literature studies now present a biophysical framework of approximately 1000 E2-E3 RING interactions, allowing both systematic trends and reductionist hypotheses to be tested across the entire E3 RING family. In this branch of the ubiquitin cascade further regulatory potential is achieved through E3 RING homo-dimerisation and hetero-dimerisation, highlighted through structural analysis of the BARD1-BRCA1 disease related heterodimer [46] . A systematic Y2H analysis revealed these interactions highly prevalent, especially through the large TRIM subfamily and PCGF proteins [47] . Concomitantly, AP-MS and CHIP-seq experiments revealed alternate PCGF-RNF2 heterodimerisations recruit RNF2 to different genomic loci in distinct protein complexes [48] , as such suggesting RING dimerisation could extend the canonical linear cascade to facilitate ubiquitination of alternate substrate proteins in trans [47] .
A second large branch of E3 ligases is represented by the multi-subunit cullin complexes. Bennett et al. [49] used systematic AP-MS to highlight individual cullin complex composition in human cultured cells, suggesting a substrate adaptor model for cullin E3 ligase regulation. Furthermore, interaction partners defined a plethora of roles for well-studied de-ubiquitinases (DUBs) in processes such as the COP9 signalsome [50] and the proteosome, together with initial insight into a wide range of previously poorly characterized DUB enzymes [51] .
Conditional/PTMa-dependent protein interactions
As addressed above, mapping of interaction profiles for enzymes and regulators involved in PTM signaling has accelerated in recent years, revealing multiple novel aspects of PTM regulated biology. One functional PTM paradigm provided by small scale studies is their ability to dynamically alter interaction partner preferences in response to stimuli. These conditional interactions can either be mediated through single modification events, or through multiple modifications in short sequence space.
In general, recognition of PTMs is often mediated through specialized domains in dedicated families of modular proteins [29] , with most interaction knowledge stemming from assaying these domains with short modified peptides. Recently, Src homology 2 domains (SH2), known to bind phospho-tyrosine residues, were tested for interactions on peptide arrays containing phospho-peptides that resemble known in vivo phospho-sites [52, 53] .
In the context of a neuronal network prediction framework these data provided a wealth of new potential conditional interactions [52] . Furthermore, remarkable interaction specificity was seen in SILAC based quantitative pull-downs that captured cellular binding partners with methylated histone-derived peptides [54, 55] . Finally, general principles of multi-site PTM recognition could be experimentally observed between structurally characterized BROMO domains and multiply-modified histone tail peptides [56] .
However, studies turn more towards models/approaches which better resemble the context of the interactions in a cell using full length proteins. For example, SRM-based interaction quantification from affinity purifications of the adapter protein GRB2 was used in combination with domain mutations and short interfering RNA knockdown probes to interrogate the conditional GRB2 interactome. Bisson et al. [57] separated direct from indirect, and SH3-domain from SH2-domain mediated (i.e. phosphorylation-dependent), interactions within a group of 90 GRB2 complex members in response to distinct stimuli. Another approach used the Polo-box domain of polo-like Kinase 1, a domain that preferentially binds phosphoproteins, to purify 622 proteins from cell cycle arrested osteosarcoma U2OS cell lysates which were co-enriched for the optimal PLK phospho-binding and PLK1 phosphorylation-site motifs [58] .
These affinity purification studies reveal mostly correlative information about PTM-dependent complex formation, with either the modification-site or the recognition site known and both direct or indirect relationships have explanatory potential (Table 2) . A deeper mechanistic understanding implies knowledge about PTM-mediated interactions, where both the modified site and the corresponding recognition site are known. Recent medium scale studies have begun to address these complexities using selective reaction monitoring (SRM) based MS techniques to investigate PTM-mediated interactome alterations ( Figure 1B(iv) ). In an integrated approach, using a combination of peptide array, bioinformatic analysis and SRM based MS analysis, Liu et al. [59 ] identified 40 lysine methylation sites across 28 proteins that associated with the chromo domain containing heterochromatin binding protein HP1b. They then highlighted the functional relevance of DNA-PKcs methylation mediated HP1b interaction in the DNA damage response [59 ] . Elucidating both PTM-dependent and PTM-mediated complex formation, Zheng et al. [60 ] recently tracked the relative abundance of a subset of 41 SHC1 interacting proteins during EGF stimulation and correlated these with both early pY and later pS/T modifications. A phospho-Y313-mediated, proliferative Grb2-dependent cluster of proteins bound 1-3 min after EGF treatment. At 3-9 min, the SHC1-S29 Akt-phosphosite resulting from this activation starts the signal termination, that is, recruitment of a distinct set of proteins including Ptpn12, a tyrosine phosphatase displacing SHC1 from the receptor. During the late response SHC1 somehow recruits proteins involved in cytoskeletal dynamics that cluster with phosphorylation of SHC1-T147 and S335. Although the late phospho-dependent signal flow is not understood these phospho-sites are crucial for restricting proliferation. Formation of this signaling complex depends on the PTMs, therefore the interaction isolation through IP provided the necessary enrichment to correlate the dynamics of multiple interacting species simultaneously with the dynamics of SHC1 phosphorylation in EGF-signaling [60 ] .
The literature provides excellent examples of studies starting to elucidate phosphorylation-dependent signaling networks in detail and first network approaches Table 2 PTM-dependent and PTM-mediated interactions. Examples illustrating potential mechanisms for interactions/co-complex formation influenced by PTMs. ) [96] addressing the recognition of other PTMs, such as Kacetylation or K/R-methylation are also under way. However, systematic studies that assess the potential of Ub and Ub-like dependent interactions in signaling are elusive. 20 families of Ub binding proteins with the potential to recognize non-degradation triggering, alternatively conjugated Ub chains and the various Ub-like protein modifications suggest these interactions are prevalent yet poorly sampled [41, 42] . Furthermore Ub/Ub-like PTMs are proteins in their own right, therefore the storage of thousands of covalent Ub modification events in interaction databases makes systematically dissecting genuine Ub-modification dependent interactions difficult.
Conclusions
In general, systematic investigation linking specific PTMs to large scale alterations in network structure have lagged behind due to the technical challenges inherent in connecting two large scale measurements, that is, protein interaction data and protein modification data. Combining recent MS studies and literature datasets, over 100,000 modifications across more than 12,000 unique proteins have been identified in human cells. PTM data sets are difficult to normalize and interpret because of extensive enrichment protocols, incomplete sampling, miscalls, large differences in protein abundance [61] , different PTM-occupancy levels [62] and relatively low PTM-site conservation [63,64 ,65 ] . In addition most PTMs may not function alone [64 ,65 ,66 ] yet experimental strategies to tackle these dependencies are just being developed [67] . However, upon changing conditions, PTMs do show massive dynamic responses with hundreds to thousand dynamic PTM-site changes [62, 68, 69] , providing a strong argument for their functional importance. Predicting putative enzyme-site relationships, for example, using an integrative Bayesian approach [70] , clustering dynamic changes throughout the cell cycle [62] or in stem cell development [69] , or examining evolutionary conservation and structural relationships [64 ,65 ] can all be informative in identifying PTM functionality. However, as the MS studies described above highlight [59 ,60 ] , an additional appropriate data filter for prioritizing the functionally most relevant PTM-signals is interaction network context. The first large MS study measuring lysine-acetylation reported that acetylation accumulates over protein complexes in human cultured cells [71] and high phosphorylation levels were observed on specific subunits of mitotic complexes [72] . Supporting and extending this idea, a first computational analysis of global acetylation, phosphorylation and ubiquitylation data revealed that modifications cluster within interaction networks [66 ] . Furthermore PTMi spots, short disordered amino acid stretches with exceptional high PTM density, were found in more than 400 human proteins and may be important sites for PTM-mediated recognition events [66 ] . These studies suggest that analysis of PTMs coupled to protein interaction information will promote a better understanding of enzyme-substrate relationships, the dynamics of PTM-mediated signal flow and the consequences of PTM-mediated recognition events, that is, the rewiring of molecular networks as a signaling response. Function clusters within protein interaction networks. Just as the interpretation of the large number of genetic variation between genomes is greatly aided by network information, evidence is piling up that proteinprotein interaction networks will be successfully exploited in the analyses of the more than 100,000 cellular PTMs. 
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